Yahoo
Nasdaq - Delayed Quote USD

Janus Henderson Global Life Sciences C (JFNCX)

74.44 +1.91 (+2.63%)
At close: 8:06:40 AM EDT
Chart Range Bar
Loading chart for JFNCX
  • Previous Close 72.53
  • YTD Return 6.91%
  • Expense Ratio 1.79%
  • Category Health
  • Last Cap Gain 37.00
  • Morningstar Rating
  • Morningstar Risk Rating Above Average
  • Net Assets 5.8B
  • Beta (5Y Monthly) 0.69
  • Yield 0.00%
  • 5y Average Return --
  • Holdings Turnover 30.00%
  • Last Dividend 0.25
  • Inception Date Dec 31, 1998

The fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that the portfolio management believes have a life science orientation. In the fund's pursuit of companies with a life science orientation, the fund has a fundamental policy to normally invest at least 25% of its total assets in securities of companies that are categorized in the "life sciences" sector.

Janus Henderson

Fund Family

Health

Fund Category

5.8B

Net Assets

1998-12-31

Inception Date

Performance Overview

View More

Trailing returns as of 10/19/2026. Category is Health.

YTD Return

JFNCX
6.91%
Category
7.95%

1-Year Return

JFNCX
26.55%
Category
30.16%

3-Year Return

JFNCX
13.67%
Category
16.10%

5-Year Return

JFNCX
7.53%
Category
15.71%

People Also Watch

Holdings

View More

Top 10 Holdings (42.22% of Total Assets)

Symbol Company % Assets
Eli Lilly and Company 9.05%
Johnson & Johnson 7.48%
AbbVie Inc. 4.63%
UnitedHealth Group Incorporated 4.33%
AstraZeneca PLC 3.50%
Thermo Fisher Scientific Inc. 2.92%
Novartis AG 2.78%
Roche Holding AG 2.63%
argenx SE 2.55%
Abbott Laboratories 2.36%

Sector Weightings

Top Mutual Funds

Mobilize your Website
View Site in Mobile | Classic
Share by: